Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea · Delayed Price · Currency is KRW 91,600
+100 (0.11%)
At close: Mar 20, 2026
Mezzion Pharma Market Cap
Mezzion Pharma has a market cap or net worth of 2.78 trillion as of March 20, 2026. Its market cap has increased by 224.75% in one year.
Market Cap
2.78T
Enterprise Value
2.77T
Revenue
7.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
91,600.00
Market Cap Chart
Since January 20, 2012, Mezzion Pharma's market cap has increased from 240.02B to 2.78T, an increase of 1,059.44%. That is a compound annual growth rate of 18.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 2.78T | 1.72% |
| Dec 30, 2025 | 2.74T | 195.96% |
| Dec 30, 2024 | 924.37B | -19.89% |
| Dec 28, 2023 | 1.15T | 231.92% |
| Dec 29, 2022 | 347.65B | -82.01% |
| Dec 30, 2021 | 1.93T | 23.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.11T |
| Celltrion | 44.21T |
| Sam Chun Dang Pharm. | 21.09T |
| ALTEOGEN | 18.91T |
| ST Pharm | 3.13T |
| Hugel | 2.88T |
| Hanall Biopharma | 2.87T |
| Orum Therapeutics | 2.68T |